The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca

Journal of Ocular Pharmacology and Therapeutics

Volumn 14, Issue 6, 1998, Pages 497-504

  Solomon, Abraham ^a   Merin, Saul ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; GLYCEROL; HYALURONIC ACID; L 02A; ROSE BENGAL; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG FORMULATION; HUMAN; KERATOCONJUNCTIVITIS SICCA; PATIENT SATISFACTION; SCORING SYSTEM; STAINING; TREATMENT OUTCOME;

EID: 0031698410     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1998.14.497     Document Type: Article

References (16)

1. Holly, F.J. and Lemp, M.A. Tear physiology and dry eyes. Surv. Ophthalmol. 22:69-87, 1977.
2. Lemp, M.A. and Chacko, B. Diagnosis and treatment of tear deficiencies. In Duane's Clinical Ophthalmology, Tasman, W., Jaeger, E.A. ed., Lippincott - Raven, Philadelphia, 1996, vol. 4, ch. 14, pp.1-13.
3. Nelson, J.D. and Farris, R.L. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. Arch. Ophthalmol. 106:484-487, 1988.
4. Sand, B.B., Marner, K., and Norn, M.S. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial. Acta Ophthalmol. 67:181-183, 1991.
5. Laroche, L., Arrata, M., and Brasseur, G. Traitement de la se'cheresse oculaire par gel lacrymal: e'tude multicentrique randomise'e. J. Fr. Ophthalmol. 14:321-326, 1991.
6. Abelson, M.B. and Knight, E. Dry eye therapy: evaluation of current directions and clinical trials. In Lacrimal gland, tear film and dry eye syndromes, Sullivan, D.A., ed., Plenum Press, New York, 1994, pp. 431-436.
7. Dikstein, S. (Based on patents by S. Dikstein. The parent Israeli patent is No. 80298, 1986).
8. Cohen, S., Marcus, Y., Migron, Y., Dikstein, S., and Shafran, A. Water sorption, binding and solubility of polyols. J. Chem. Soc. Faraday Trans. 89:3271-3275, 1993.
9. Mazzacane, D. and Braggio, F. Randomized controlled trial of high-molecular-weight hyaluronic acid in dry eye syndromes. Ann. Ottalmol. Clin. Ocul. 119:1-15, 1993.
10. Lester, A., Brezzo, M.V., and Rolando, M. Double masked clinical trial of an unpreserved hyaluronic acid based eye drop in dry eye syndromes. Ann. Ottalmol. Clin. Ocul. 119:17-31, 1993.
11. Taiti, L., Mencucci, R., and Bardi, L. A double masked crossover comparison of a new artificial tear preparation containing hyaluronic acid (LO2A) and a reference artificial tear preparation containing hydroxypropyl-methylcellulose in dry eye syndrome treatment. Ann. Ottalmol. Clin. Ocul. 119:33-46, 1993.
12. Cerruli, L., Trematerra, M., and Zapelloni, A. Clinical evaluation of LO2A eye drop versus control eye drop in patients suffering from lacrimal hyposecretion. Ann. Ottalmol. Clin. Ocul. 119:49-55, 1993.
13. van Bijsterveld, O.P. Diagnostic tests in the sicca syndrome. Arch. Ophthalmol. 82:10-14, 1969.
14. George, M.A., Abelson, M.B., and Schafer, K. A precise method of using rose bengal in the evaluation of dry eye and the detection of changes in its severity. In Lacrimal gland, tear film and dry eye syndromes, Sullivan, D.A., ed., Plenum Press, New York, 1994, pp.540-551.
15. Shapiro, A. and Merin, S. Schirmer test and break-up time of the tear film in normal subjects. Am. J. Ophthalmol. 88:752-757, 1979.
16. Gasset, A.R., Ishii, Y., Kaufman, H.E., and Miller, T. Cytotoxicity of ophthalmic preservatives. Am. J. Ophthalmol. 78:98-105, 1974.